van de Lagemaat, Louie NFlenley, MLynch, MagnusDavid, GARRICKTomlinson, SRKranc, KRVernimmen, Douglas2024-03-132024-03-132018-10-06van de Lagemaat, L N, Flenley, M, Lynch, M, David, GARRICK, Tomlinson, SR, Kranc, KR & Vernimmen, D 2018, 'CpG binding protein (CFP1) occupies open chromatin regions of active genes, including enhancers and non-CpG islands.', Epigenetics & Chromatin, vol. 11, 59. https://doi.org/10.1186/s13072-018-0230-01756-8935ORCID: /0000-0002-2947-1557/work/140168033https://hdl.handle.net/2164/23006Funding This work was supported by a University of Edinburgh Chancellor’s Fellowship to Douglas Vernimmen and by Institute Strategic Grant funding to the Roslin Institute from the BBSRC [BB/J004235/1] and [BB/P013732/1]. Louie N. van de Lagemaat was supported by Roslin Institute funding to Douglas Vernimmen. We are very grateful to Zhanyun Tang and Bob Roeder for the CFP1 antibody. We would like to thank our colleagues Alan Archibald, Philipp Voigt and Duncan Sproul for critically reading the manuscript. We also thank Jim Hughes for curating data sets obtained in Oxford. High-throughput sequencing was provided by the Oxford Genomics Centre (http://www.well.ox.ac.uk/ogc/ home/) and Edinburgh Genomics (http://genomics.ed.ac.uk).184210537engCFP1CpG islandsTrithorax group proteinsEpigeneticsEnhancersQH426 GeneticsGeneticsBiotechnology and Biological Sciences Research Council (BBSRC)BB/J004235/1BB/P013732/1QH426CpG binding protein (CFP1) occupies open chromatin regions of active genes, including enhancers and non-CpG islands.Journal article10.1186/s13072-018-0230-0https://europepmc.org/articles/PMC617386511